ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules.
Mukhi D, Li L, Liu H, Doke T, Kolligundla LP, Ha E, Kloetzer K, Abedini A, Mukherjee S, Wu J, Dhillon P, Hu H, Guan D, Funai K, Uehara K, Titchenell PM, Baur JA, Wellen KE, Susztak K.
Mukhi D, et al. Among authors: baur ja.
J Clin Invest. 2023 Dec 5;134(4):e172963. doi: 10.1172/JCI172963.
J Clin Invest. 2023.
PMID: 38051585
Free PMC article.